Sign inJoin waitlistJoin the waitlist

Cheryl Czerlanis

Professor · University of Wisconsin Hospitals and Clinics

Credentials: · · · · ·

History

University of Wisconsin Hospitals and Clinics
Present
University of Wisconsin-Madison
Present

Hematology and Medical Oncology
2004–2007
Internal Medicine
Loyola University Medical Center
2001–2004
Loyola University Chicago Stritch School of Medicine
1997–2001

Research

Learning-dependent dendritic hypertrophy of cerebellar stellate cells: plasticity of local circuit neurons
Neurobiology of Learning and Memory · 1997 · 56 citations
Retrospective utility of bronchoscopy after hematopoietic stem cell transplant
Bone Marrow Transplantation · 2006 · 47 citations
Structural stability within the lateral cerebellar nucleus of the rat following complex motor learning
Neurobiology of Learning and Memory · 1998 · 27 citations

PS
Patrick Stiff
6 papers
Craig Hofmeister
2 papers · 1 as a fellow
EH
Elizabeth Henry
2 papers
Kathy Albain
2 papers
Michelle Pipitone
2 papers
Abigail Winder
1 paper
AS
Albert Sohn
1 paper
AC
Allison Chang
1 paper · 1 as a fellow
Amit Goyal
1 paper
Constantine Godellas
1 paper
DP
Daniel Peiffer
1 paper · 1 as a fellow
DM
David Marinier
1 paper · 1 as a fellow

Grants

UW Comprehensive Cancer Center Support
National Cancer Institute · P30
Project lead · $14.2K · University of Wisconsin-Madison
1997–2028

Clinical trials

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer
Principal investigator · Withdrawn · Phase 2
Loyola University
2010–2012
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network
2025–2028
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028